CBER's Dozen: Novel Biologics Approved In 2015
An interactive chart listing the novel biologics cleared by FDA's Center for Biologics Evaluation and Research in 2015.
You may also be interested in...
Keeping Track: 2021’s First Novel Approvals Go To HIV And Heart Failure Therapies Opdivo Starts Year With A Bang
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Even in the grip of the pandemic, review times for priority drugs were also consistent with the last three years.
Influence of expedited review pathways and regulatory incentives is on display in 2020’s novel approvals, which have a composition reassuringly consistent with recent years.